These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12783977)

  • 21. BCR/ABL fusion gene detected on 9q34 by fluorescence in situ hybridization in an acute leukemia with two BCR/ABL positive clones, one Ph-negative and one Ph-positive.
    Terré C; Bastie JN; Garcia I; Suzan F; Cayuela JM; Therond P; Castaigne S
    Cancer Genet Cytogenet; 2001 Nov; 131(1):37-41. PubMed ID: 11734316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
    Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
    Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of Bcr/Abl gene rearrangement in chronic myelogenous leukemia patients by dual-color dual-fusion fluorescence in situ hybridization].
    Guo B; Zhu HL; Li SX; Lu XC; Fan H; Zhao DD; Han XP; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):261-5. PubMed ID: 19379547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
    Acar H; Stewart J; Connor MJ
    Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
    Mohr B; Bornhäuser M; Platzbecker U; Freiberg-Richter J; Naumann R; Prange-Krex G; Mohm J; Kroschinsky F; Ehninger G; Thiede C
    Cancer Genet Cytogenet; 2001 Jun; 127(2):111-7. PubMed ID: 11425449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions.
    May PC; Reid AG; Robinson ME; Khorashad JS; Milojkovic D; Claudiani S; ; Willis F; Apperley JF; Innes AJ
    BMC Med Genomics; 2023 Jul; 16(1):172. PubMed ID: 37496024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
    Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
    Dewald GW; Wyatt WA; Silver RT
    Leuk Lymphoma; 1999 Aug; 34(5-6):481-91. PubMed ID: 10492071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia.
    Robinson HM; Martineau M; Harris RL; Barber KE; Jalali GR; Moorman AV; Strefford JC; Broadfield ZJ; Cheung KL; Harrison CJ
    Leukemia; 2005 Apr; 19(4):564-71. PubMed ID: 15716990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
    Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
    Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization].
    Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Implications of Derivative Chromosome 9 Deletions in Patients with Advanced-Stage Chronic Myelogenous Leukemia.
    Chandran RK; Geetha N; Sakthivel KM; Aswathy CG; Gopinath P; Nair JKKM; Sreedharan H
    J Environ Pathol Toxicol Oncol; 2018; 37(2):117-126. PubMed ID: 30055547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of variant translocations in chronic myeloid leukemia by fluorescence in situ hybridization.
    Acar H; Stewart J; Boyd E; Connor MJ
    Cancer Genet Cytogenet; 1997 Feb; 93(2):115-8. PubMed ID: 9078295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients.
    Bennour A; Ouahchi I; Ben Youssef Y; Zaier M; Laatiri MA; Harrabi I; Meddeb B; Elloumi M; Khelif A; Saad A; Sennana H
    Med Oncol; 2012 Jun; 29(2):1151-60. PubMed ID: 21461967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia.
    Yoong Y; VanDeWalker TJ; Carlson RO; Dewald GW; Tefferi A
    Eur J Haematol; 2005 Feb; 74(2):124-7. PubMed ID: 15654903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization.
    Cetin Z; Yakut S; Karadogan I; Kupesiz A; Timuragaoglu A; Salim O; Tezcan G; Alanoglu G; Ozbalci D; Hazar V; Yesilipek MA; Undar L; Luleci G; Berker S
    Genet Test Mol Biomarkers; 2012 May; 16(5):318-23. PubMed ID: 22360868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
    Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
    Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.